Found 0 matching trials
PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer PHASE2 This study evaluates Patient-derived Tumor-like Cell Clusters (PTC)-guided ...
Show More Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Learn More & Join Trial
Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer NA The goal of this clinical trial is to evaluate the efficacy and safety of t...
Show More Location
The Central Hospital of Wuhan
Learn More & Join Trial
Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test N/A This study prospectively included 150 breast cancer patients (30 patients i...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma PHASE2 The purpose of this study is to evaluate the effectiveness and safety of th...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy EARLY_PHASE1 Modification of the EGF signalling pathway and / or HER 2, by Lapatinib in ...
Show More Location
CHU Bordeaux - Hôpital Saint André - Department of Medical Oncology
Learn More & Join Trial
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01) PHASE2 This study is a prospective, single arm, multi-center phase II clinical tri...
Show More Location
The First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection PHASE1 This research study is evaluating a new type of esophagus cancer vaccine ca...
Show More Status
Active Not Recruiting
Location
The Second Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer PHASE2 This is a Phase II open study, not randomized with a neoadjuvant therapy,co...
Show More Location
Clínica Universitaria de Navarra
Learn More & Join Trial
One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer NA Background:Moderate three week hypofractionated adjuvant radiotherapy sched...
Show More Location
Sanjoy Chatterjee
Learn More & Join Trial
PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial PHASE2 This is a randomized controlled trial to determine the efficacy and safety ...
Show More Location
People's Hospital of Kaiyang County
Learn More & Join Trial